DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Cavo M, Dimopoulos MA, San-Miguel J, Jakubowiak AJ, Suzuki K, Yoon SS. et al.
Impact of baseline renal function on efficacy and safety of daratumumab plus bortezomib-melphalan-prednisone (VMP) in patients (Pts) with newly diagnosed multiple myeloma (NDMM) ineligible for transplantation (ALCYONE).
J Clin Oncol 2018;
36 (Suppl. 15) e20024
Access:
We do not assume any responsibility for the contents of the web pages of other providers.